Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus

Neuropsychopharmacology

Volumn 24, Issue 6, 2001, Pages 608-616

  Levkovitz, Y ^a   Grisaru, N ^a   Segal, M ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Dentate gyrus; Depression; Desipramine; Mianserin; TMS

Indexed keywords

ANTIDEPRESSANT AGENT; DESIPRAMINE; FENFLURAMINE; MIANSERIN; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL EXCITABILITY; NERVE CELL INHIBITION; NONHUMAN; PERFORANT NERVE TRACT; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; SPIKE; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

ACTION POTENTIALS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; DESIPRAMINE; ELECTRIC STIMULATION; ELECTRIC STIMULATION THERAPY; EXCITATORY POSTSYNAPTIC POTENTIALS; FENFLURAMINE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MIANSERIN; NEURAL INHIBITION; NEURONS; RATS; RATS, LONG-EVANS; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 0035025194     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00244-X     Document Type: Article

References (29)

1. Barker A.T. An introduction to the basic principles of magnetic nerve stimulation. J Clin Neurophysiol. 8:1991;26-37.
2. Barker A.T., Freeston I.L., Jalinous R., Jarratt J.A. Clinical evaluation of conduction time measurements in central motor pathway using magnetic stimulation of human brain. Lancet. 1:1986;1325-1326.
3. Blier P., deMontigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 15:1994;220-226.
4. Bliss T.V., Goddard G.V., Rlives M. Reduction of long-term potentiation in the dentate gyrus of the rat following selective depletion of monoamines. J Physiol. 334:1983;475-491.
5. Burt D.B., Zembar M.J., Niederehe G. Depression and memory impairment. A meta analysis of the association, its pattern, and specificity Psychol Bull. 117:1995;285-305.
6. Cohen L.G., Roth B.J., Nilsson J., Dang N., Panizza M., Bandinelli S., Friauf W., Hallett M. Effects of coil design on delivery of focal magnetic stimulation. Electroencephal Clin Neurophysiol ; 75:1990;350-357.
7. Delgado P.L., Miller M.L.L., Solomon R.M., Van Vilthoven V., Heninger G.R., Charney D.S. Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan Arch Gen Psychiat. 47:1990;411-418.
8. Gates J.R. Transcranial magnetic stimulation. Neuroimaging Clin N Am. 5:1995;711-720.
9. George M.S., Wasermann E.M., Williams W.A., Callahan A., Ketter T.A., Basser P., Hallett M., Post R.M. Daily repetitive transcranial magnetic stimulation improves in refractory depression. Neuroreport. 6:1995;1853-1856.
10. Grisaru N., Yaroslavsky U., Abarbanel J., Lamberg T., Belmaker R.H. Transcranial magnetic stimulation in depression and schizophrenia. Eur Neuropsychopharmacol. 4:1994;287-288.
11. Haddjeri N., Blier P., Montigny C. Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors. J Neurosci. 18:1998;10150-10156.
12. Hallett M., Cohen L.G. Magnetism. A new method for stimulation of nerve and brain JAMA. 262:1989;538-541.
13. Hoflich G., Kasper S., Hunfnagel A., Ruhrmann S., Moller H.J. Application of transcranial magnetic stimulation in treatment of drug resistance major depression - Report of two cases. Hum Psychopharmacol. 8:1993;361-365.
14. Juckel G., Mendlin A., Jacobs B.L. Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output. Implications for electroconvulsive therapy and transcranial magnetic stimulation in depression Neuropsychopharmacology. 21:1999;391-398.
15. Kessel J.B., Simpson G.M. Tricyclic and tetracyclic drugs. Kaplan H.I., Sadock B.J. Comprehensive Textbook of Psychiatry. 1995;Baltimore, p 2096, Williams & Wilkins.
16. Klein E., Kreinin I., Chistyakov A., Koren D., Mercz L., Marmur S., Ben-Shachar D., Feinsod M. Therapeutic efficacy of right prefrontal slow repetitive treanscranial magnetic stimulation in major depression. A double-blind controlled study Arch Gen Psychiat. 56:1999;315-320.
17. Krishnan K.R., Doraiswamy P.M., Figiel G.S., Husian M.M., Shah S.A., Na C., Boyko O.B., McDonald W.M., Nemeroff C.B., Ellinwood E.H. Jr. Hippocampal abnormalities in depression. J Neuropsychiat Clin Neurosci. 3:1991;387-391.
18. Laroche S. What can the long-term potentiation procedure tell us about the neural mechanisms of learning and memory? Will B.E., Schmitt P., Dalrymple-Alford J.C. Advances in Behavioral Biology, vol. 28, Brain Plasticity, Learning, and Memory. 1985;139-155 Plenum, New York.
19. Levkovitz Y., Segal M. Serotonin 5-HT1A receptors modulate hippocampal reactivity to afferent stimulation. J Neurosci. 17:1997;5591-5598.
20. Levkovitz Y., Marx J., Grisaru N., Segal M. Long-term effects of transcranial magnetic stimulation on hippocampal reactivity to afferent stimulation. J Neurosci. 19:1999;3198-3202.
21. Richter-Levin G., Segal M. The effects of serotonin depletion and raphe grafts on hippocampal electrophysiology and behavior. J Neurosci. 11:1991;1585-1596.
22. Shah P.J., Embeier K.P., Glabus M.F., Goodwin G.M. Cortical gray matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. Br J Psychiat. 172:1998;527-532.
23. Sheline Y.I. Hippocampal atrophy in major depression. A result of depression-induced neurotoxicity? Mol Psychiat. 4:1996;298-299.
24. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent depression. 93:1996;3908-3913.
25. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy woman with recurrent major depression. J Neurosci. 19:1999;5034-5043.
26. Shopsin B., Gershon S., Golstein M. The use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients. Psychopharmacol Com. 1:1975;239-249.
27. Vaidya V.A., Suiciak J.A., Du F., Duman R.S. Hippocampal mossy fiber spouting induced by chronic electroconvulsive seizures. Neuroscience. 89:1999;157-166.
28. Yoshioka M., Matsumoto M., Numazawa R., Togashi H., Smith C.B., Saito H. Changes in the regulation of 5-HT release by alpha 2-adrenoreceptors in the rat hippocampus after long-term desipramine treatment. Eur J Pharmacol. 294:1995;565-570.
29. Wang H., Scheich H. LTD and LTP induced by transcranial magnetic stimulation in auditory cortex. NeuroReport. 7:1996;521-525.